COVID 19

Covid-19 vaccine from Pfizer and BioNTech is strongly effective, early data from large trial indicate

By MATTHEW HERPER @matthewherper NOVEMBER 9, 2020 Pfizer and partner BioNTech said Monday that their vaccine against Covid-19 was strongly effective, exceeding expectations with results that are likely to be met with cautious excitement — and relief — in the face of the global pandemic. The vaccine is the first to be tested in the United States to generate

Latinx COVID-19 health inequities: Insights for the health care field

In recognition of Hispanic Heritage Month, the American Medical Association (AMA) released a new report emphasizing the starkly disproportionate Latinx COVID-19 cases and fatalities — further underscoring concerns that a lack of consistent data reporting underestimates the pandemic’s magnitude on the Latinx community and illustrating how the pandemic has deepened pre-existing inequities. The

The pandemic’s effect on the widening gap in mortality rate between the U.S. and peer countries

By Giorlando Ramirez, Krutika Amin, and Cynthia Cox Twitter COVID-19 deaths in the United States have surpassed 200,000, and the coronavirus is now the third leading cause of death in this country, after heart disease and cancer. Before the pandemic, the U.S. already had the highest overall mortality rate among similarly large and wealthy countries,